INHALABLE PHARMACEUTICAL COMPOSITION COMPRISING THE PROTEIN ANAKINRA FOR THE TREATMENT OF… Application WO-2023203586-A1 World Intellectual Property Organisation (WIPO) 26 Oct 2023
Composizione farmaceutica inalabile comprendente la proteina anakinra per il trattamento… N/A IT-202200007844-A1 Italy 21 Oct 2023
USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS Application WO-2021074025-A1 World Intellectual Property Organisation (WIPO) 22 Apr 2021
USO DI ESCULENTINA E SUOI DERIVATI PER USO PER IL TRATTAMENTO DELLA FIBROSI CISTICA Application IT-201900018938-A1 Italy 16 Apr 2021